/stocks — the workspaceLOADING
Jasper Therapeutics, Inc. (JSPR) is a biological products, (no diagnostic substances) company. Next earnings projected around 2026-08-12 from JSPR's year-over-year reporting pattern (not yet company-confirmed). Fundamentals from SEC filings; prices are end-of-day.
EOD daily bars · delayed, not real-time · data: DatabentoCharting by TradingView Lightweight Charts™
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
Not reported in XBRL for this filer.
A plain-English read on JSPR plus an auto-SWOT — built from JSPR's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate JSPR using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
Projected from JSPR's own SEC 8-K filing history — the year-over-year reporting pattern (~50% land the exact day, ~90% within a week). No analyst estimates, no scraped calendars, nothing invented. It upgrades to a confirmed date + time the moment JSPR files its announcement.
JSPR has rallied after 4 of its last 7 earnings reports.
Large earnings reactions have been common.
JSPR has traded higher after most recent earnings releases.
The average is inflated by its most volatile prints (+6.6% and -16.6%).
A more typical earnings reaction has been approximately ±6.3%.
Realized close-to-close history only — no options-implied move, no analyst estimates.
| Reported | Close-to-close |
|---|---|
| 2026-05-14 | -7.6% |
| 2026-03-30 | -16.6% |
| 2025-11-10 | -4.5% |
| 2025-08-13 | +6.3% |
| 2025-05-12 | +6.6% |
| 2025-02-27 | +2.2% |
| 2024-11-07 |
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
| +3.5% |